<DOC>
	<DOCNO>NCT03090178</DOCNO>
	<brief_summary>Atopic dermatitis chronic disease high impact patient 's quality life . Nocturnal pruritus one main symptom affect quality life . Treatment efficacy generally measure healthcare professional consultation question visual examination lesion . Quality Life ( QoL ) also evaluate retrospectively Dermatology Life Quality Index ( DLQI ) scale . Collecting data retrospectively introduces significant recall bias address collect data Real World ( RW ) . Real World data collection prospective take place within patient 's environment . While data collection generally do diary , demonstrate smartphone connect device able produce precise granular data traditional method .</brief_summary>
	<brief_title>Sleep &amp; Quality Life Evaluation Patients With Atopic Dermatitis Based E-diary Smartphone Application Actigraphy</brief_title>
	<detailed_description>The main objective study demonstrate medical hypothesis use wristband actigraph : patient moderate severe atopic dermatitis poorer quality quantity sleep healthy subject . Secondary objetives assess interest smartphone application evaluate quality life patient moderate severe atopic dermatitis regard healthy volunteer .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>Patients : Subjects use smartphone run Apple operating system ( iOS 7 ) Android ( version 2.2 ) Subjects agree wear actigraphy wristband night Subjects 18 year old old Subjects affiliate French Health Insurance Subjects treat moderate severe atopic dermatitis atopic dermatitis exacerbation* *The stage atopic dermatitis assess use Eczema Area Severity Index ( EASI ) , Body Surface Area ( BSA ) Investigator Global Assessment ( IGA ) . The EASI investigatorassessed instrument measure severity clinical sign atopic dermatitis . The EASI identify one bestvalidated outcome measure atopic dermatitis . A moderate severe atopic dermatitis corresponds : Eczema Area Severity Index score ≥ 7.1 Investigator Global Assessment ≥ 3 Body Surface Area ≥ 10 Healthy volunters : Subjects use smartphone run iOS ( iOS 7 ) Android ( version 2.2 ) Subjects agree wear actigraphy wristband night Subjects 18 year old old Subjects affiliate French Health Insurance Subjects without dermatology disease Non inclusion Criteria : Illiterate subject Subjects proficient French Subject primary insomnia* *Insomnia , sleep apnea hypersomnia evaluate respectively 3 test : Insomnia Severity Index ( ISI ) ; Berlin Sleep Apnea Scale ; Epworth Scale Subjects treat hypnotic drug Pregnant woman Subjects guardianship Exclusion criterion : If participant take hypnotic treatment study participation , exclude clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>